Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

ALDACTAZIDE® Principal Display Panel (spironolactone, hydrochlorothiazide)

PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label - 1011

NDC 0025-1011-31

Pfizer

Aldactazide®
spironolactone and
hydrochlorothiazide
tablets

25 mg / 25 mg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label - 1011

PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label - 1021

NDC 0025-1021-31

Pfizer

Aldactazide®
spironolactone and
hydrochlorothiazide
tablets

50 mg / 50 mg

100 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label - 1021
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event